Alivus Life Sciences Limited has informed the Exchange about Schedule of meet
ALIVUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Alivus Life Sciences Limited (formerly Glenmark Life Sciences Limited) has informed the stock exchanges about a scheduled meeting with Green Lantern Capital on August 26, 2025. The meeting will be held in-person in Mumbai in a one-on-one format and will be attended by company representatives. The filing is a routine compliance disclosure under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015. No financial results, business updates, or material information were shared in this intimation.
This is a routine regulatory disclosure and is unlikely to have any direct impact on the stock price. Investors should watch for any subsequent disclosures or presentations that may come out of this meeting for potential business or strategic updates.